Susvimo is a unique therapeutic approach that provides continuous delivery of medicine to the eye through a refillable implant
Lupin can receive a potential total consideration of up to USD 84 million based on future contingent milestones
Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies
Acquisition provides Ligand with the royalty rights to QARZIBA, a highly differentiated, commercial oncology drug marketed in 35 countries by global pharmaceutical company Recordati S.p.A.
India boasts the largest livestock population, with 536 million livestock and 851 million poultry
Felzartamab demonstrated positive interim results from the Phase 2 IgA nephropathy (IgAN) study
Dyslipidemia is a critical risk factor for cardiovascular diseases
CureVac receives €400 million upfront and up to an additional €1.05 billion in development, regulatory and sales milestone payments as well as tiered royalties; all previous financial considerations from the prior collaboration agreement replaced
States urged to maintain a state of constant vigil through screening of pregnant women for Zika virus infection and monitoring the growth of foetus of expecting mothers who tested positive for Zika
Subscribe To Our Newsletter & Stay Updated
